InMed Pharmaceuticals (FRA:MWG) Other Long Term Assets : €0.09 Mil (As of Mar. 2025)

View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Other Long Term Assets?

InMed Pharmaceuticals's other long-term assets for the quarter that ended in Mar. 2025 was €0.09 Mil.

InMed Pharmaceuticals's quarterly other long-term assets increased from Sep. 2024 (€0.09 Mil) to Dec. 2024 (€0.09 Mil) but then stayed the same from Dec. 2024 (€0.09 Mil) to Mar. 2025 (€0.09 Mil).

InMed Pharmaceuticals's annual other long-term assets declined from Jun. 2022 (€0.17 Mil) to Jun. 2023 (€0.10 Mil) and declined from Jun. 2023 (€0.10 Mil) to Jun. 2024 (€0.09 Mil).

InMed Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for InMed Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Other Long Term Assets Chart

InMed Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long Term Assets

Get a 7-Day Free Trial

0.01

0.17

0.10

0.09

InMed Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															0.09	0.09	0.09	0.09	0.09

InMed Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

InMed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InMed Pharmaceuticals Inc (FRA:MWG) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

INM:USA MWG:Germany

Address

885 West Georgia Street, Suite 1445, Vancouver, BC, CAN, V6C 3E8

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.